The GP129, GP131 and GP133 genes of guinea pig cytomegalovirus (GPCMV) are homologues of human cytomegalovirus UL128, UL130 and UL131A, respectively, which are essential for infection of endothelial and epithelial cells, and for viral transmission to leukocytes. Our previous study demonstrated that a GPCMV strain lacking the 1.6 kb locus that contains the GP129, GP131 and GP133 genes had a growth defect in animals. Here, we demonstrated that the WT strain, but not the 1.6 kb-deleted strain, formed capsids in macrophages prepared from the peritoneal fluid. To understand the mechanism, we prepared GPCMV strains defective in each of GP129, GP131 and GP133, and found that they were all essential for the infection of peritoneal, splenic and PBMC-derived macrophages/monocytes, and for expression of immediate-early antigens in the macrophages/monocytes, although they were dispensable for infection of fibroblasts. Monocyte/macrophage tropism could be one of the important determinants for viral dissemination in vivo.
Congenital infection by human cytomegalovirus (HCMV) occurs in 0.2-1 % of all births, and causes birth defects and developmental abnormalities (Pass, 2001; Ogawa et al., 2007; Koyano et al., 2009 Koyano et al., , 2011 . In contrast to murine CMV (MCMV) and rat CMV (RCMV), guinea pig CMV (GPCMV) causes infection in utero, which makes GPCMV animal models useful for studies on congenital CMV diseases (Kern, 2006; Schleiss, 2006; Hashimoto et al., 2013) .
Previously, we noticed that the GPCMV stock purchased from the American Type Culture Collection (ATCC) was a mixture of two strains -one containing and the other lacking a 1.6 kb locus that encodes the GP129 and GP131 genes, homologues of HCMV UL128 and UL130, respectively. Importantly, the locus was required for efficient viral growth in animals but not in fibroblast cell cultures (Nozawa et al., 2008; Yamada et al., 2009) . HCMV UL128, UL130 and UL131A are essential for viral entry into endothelial and epithelial cells, as well as for viral transmission to leukocytes (Hahn et al., 2004; Wang & Shenk, 2005a, b; Adler et al., 2006; Ryckman et al., 2006) . UL128 is necessary for monocyte infection and the blocking of migration (Straschewski et al., 2011) . UL128/130/131A form a pentameric complex with glycoproteins H and L (gH and gL) (Ryckman et al., 2008) . Recently, it was reported that GPCMV GP133 is related structurally to UL131A and that GP129/131/133 form a complex with gH/gL (Auerbach et al., 2013) . Here, we examined whether GP129/131/133 are required for cell tropisms as reported for their HCMV homologues.
First, we examined whether there was any difference in viral infection of macrophages between the WT strain and the 1.6 kb-deleted strain. For this purpose, peritoneal macrophages were prepared as follows. An aliquot of 8 ml PBS containing 154 ml 2.6 % magnetic beads with a diameter of 1 mm (Magnetic Microspheres; ProMag) was injected into the peritoneal cavity of guinea pigs (8 weeks old) followed by injection of 2 ml liquid paraffin. Peritoneal fluid was recovered 5-6 days later. Cells in the fluid were collected by centrifugation, washed twice with PBS and then separated using a magnetic device. More than 90 % of the separated cells reacted with anti-CD68 (monocytes/macrophages) antibody (PM-1K; TransGenic), indicating that the collected cells were macrophages which phagocytosed magnetic beads. Macrophages were then cultured in RPMI medium supplemented with 10 % FBS and 2 mM L-glutamine, infected with the two strains, and harvested at 3 days postinfection (p.i.). Observation under an electron microscope revealed the presence of capsids in the nuclei of the macrophages infected with the WT strain, but not in those infected with the 1.6 kb-deleted strain (Fig. S1 , available in the online Supplementary Material).
To demonstrate directly that the gene product(s) in the 1.6 kb locus is essential for the macrophage tropism, we prepared pBAC-GPCMVD9K, a bacterial artificial chromosome (BAC) that contains a GFP expression cassette and the GPCMV genome lacking an 8.9 kb sequence (Fig.  1a) . Although two versions of pBAC-GPCMV have been reported, one lacks the 1.6 kb locus and the other has mutations in the GP129 gene (McGregor & Schleiss, 2001; Cui et al., 2008; Kanai et al., 2011) . In addition, as the GPCMV genome rearranges frequently if its length exceeds the packagable size (Cui et al., 2009 ), use of GFP as a marker for infection requires a deletion to compensate for the length of the foreign sequence. Such a deletion was introduced in the sequence 4248-13 029 (the numbers are based on Kanai et al., 2011) in which gp1 (12 964-12 659; vMIP-1B homologue) is the only predictable gene. pBAC-GPCMVD9K was prepared as follows. Fragments covering positions 2642-4247 and 13 030-14 482 were cloned into pBluescript II KS(+), and a loxP sequence was introduced in the unique NsiI site of the plasmid using linkers P1 and P19 (Table S1 ). Next, pBeloBAC11 (New England BioLabs) containing a CMV MIE promoter-GFP gene-SV40 poly(A) cassette was inserted into the loxP site by in vitro Cre reaction, resulting in pBS-AHE-BAC. pBS-AHE-BAC was then co-transfected with nucleocapsid DNA prepared from GPCMV(SG-P5), which was derived from the salivary glands of a GPCMV(strain 22122; ATCC)-infected guinea pig and had been amplified by five passages in vitro. GFPpositive plaques were purified a few times to obtain GPCMV-BACD9K, a GPCMV that contains the BAC-GFP cassette between positions 3992 and 3993, and lacks the sequence 4248-13 029 (Fig. 1a) . DNA was prepared from the nuclear fraction of GPCMV-BACD9K-infected cells by the method of Hirt (1967) and electroporated into DH10B (Invitrogen) to obtain pBAC-GPCMVD9K. Although the integrity of the obtained BAC was confirmed by digestions with NotI and HindIII, confirmation of its entire sequence will be required.
A stop codon mutation with a frameshift mutation was introduced into each of the GP129, GP131 and GP133 genes, and WT and mutant viruses were prepared from the same backbone as follows. First, the rpsL-neo cassette was amplified by PCR using P2 and P3 primers, and replaced the GPCMV region 197 336-198 568, which contains the first GP129 exon, the GP131 exons and the GP133 ORF, using the RedET recombination system (GeneBridges), resulting in pBAC-GPCMVD9K : : rpsL-neo (3C3) (Fig. 1b) . Next, a plasmid containing the positions 196 824-202 454 was constructed and mutagenized using a commercial kit (QuikChangeII XL; Agilent) with the primers P4-P9. The rpsL-neo cassette was replaced with the GPCMV sequences containing the WT or mutated sequences by electroporation of the PCR fragments (197 161-198 918) amplified from the plasmids using primers P10 and P11 (Fig. 1c) .
BAC-derived viruses containing the WT or mutated sequences in the GP129/131/133 genes, WT, GP129Stop, GP131Stop, and GP133Stop, (Fig. 1d-g ) were recovered by transfection of the BAC constructs into guinea pig fibroblast GPL cells. After observation of plaque formation, viruses were amplified a couple of times by co-culturing of infected cells with uninfected cells. Finally, cell-free virus stocks were prepared and concentrated by ultracentrifugation (82 000 g for 2 h) in a 20 % sucrose step gradient. To avoid any problems due to the spontaneous occurrence of secondary mutations during the preparation of BAC clones, virus stocks were prepared from two independent BAC clones for each strain. Sequences of the GP129-133 locus (positions 196 707-198 701) of all BAC clones and the viruses were confirmed. In addition, PCR-RFLP analysis of the GPCMV-BAC-derived viruses demonstrated no apparent differences in the genome structures between WT and mutants (Fig.  S2 ). As the stocks from the two clones in each pair behaved similarly in the following experiments, results obtained from one of them are shown below. Titres of the GPCMV-BAC stocks were determined by counting GFP-positive foci after infection of GPL cells. Although the infectivity depended on cell types, we used those titres to calculate m.o.i.
First, there was no significant difference in the level of viral DNA accumulation in GPL cells infected with the WT and mutant viruses at an m.o.i. of 0.5 (Fig. 1h) . In addition, the amounts of viral DNA in culture supernatants (Fig. 1i ) were similar to, or slightly larger than, those of the WT virus. To ensure that the viral loads measured by quantitative (q) PCR were in parallel with infectious units, the numbers of GFP-positive foci were counted for the supernatants obtained at 72 h p.i. Again, there was no difference in the titres (Fig. 1j) . The WT and mutant viruses infected another guinea pig fibroblast cell line 104C1 (JCRB Cell Bank) at a similar level (data not shown). These results were consistent with our previous observations (Nozawa et al., 2008) . In addition, there was no difference in the level of infection of primary fibroblasts prepared from the lung among the WT and mutant viruses (Fig. 2a) , although Auerbach et al. (2013) reported that their deletion mutants in the locus showed inhibited growth in primary fibroblasts slightly.
Although infection of the epithelial cell line GPC-16 (CCL-242; ATCC) with GPCMV at an m.o.i. of 3 did not generate any detectable signals of early antigen expression (Nozawa et al., 2008) , GFP expression was observed in 5-10 % of GPC-16 cells infected with GPCMV-BAC at an m.o.i. of 5 and a very small part of GFP-positive cells formed foci .7 days p.i., suggesting inefficient and slow viral growth. Nevertheless, the WT and mutant viruses infected GPC-16 at similar levels, and there was no significant difference in viral spread (Fig. 2b) . Viral transmission from GPC-16 cells incubated for 3 days p.i and then treated with 40 nM citrate buffer (pH 2.8) to overlaid GPL cells was observed without any differences among the WT and mutant viruses in 1 day (data not shown). In contrast, epithelial cells, but not other cell types, in primary renal cell cultures were resistant against infection with any strains (Fig. 2c) . This inconsistency between GPC-16 and primary cells is not due to the contamination of other cell types into the GPC-16 culture, as the cell morphology was as expected and all GPC-16 cells reacted with anti-cytokeratin antibody (OV-TL; Dako).
The observations that MCMV and HCMV cross the species barrier at certain levels, including viral entry and DNA penetration into the nuclei (Lafemina & Hayward, 1988; Tang & Maul, 2006) , together with the lack of available guinea pig fibroblast and epithelial cells from various sources, led us to examine GFP expression in four fibroblast and 10 epithelial cell lines from other species after infection. Although there were no differences in infectivity of those cell lines between the WT and mutant viruses, as entry into those cells was extremely inefficient, it was difficult to draw any conclusions. In addition to peritoneal macrophages, monocytes/macrophages were prepared from the spleens as follows. Cells in the spleens were filtered through a nylon mesh (40 mm Cell Strainer; BD Falcon), collected by centrifugation, treated with a buffer to lyse red cells, washed with PBS and cultured in a medium with or without 100 nM phorbol 12-myristate 13-acetate (PMA). The PMA treatment was intended to increase the number of macrophages (Taylor-Wiedeman et al., 1994) . One day later, the cells not attached to the wells were discarded, and the remaining cells were cultured for an additional 1-2 days and then infected with GPCMV.
Expression of GFP was observed in the peritoneal macrophages and splenic monocytes/macrophages infected with the WT virus but not with the mutants (Fig. 3a, b) . As small-sized splenic cells that did not attach to the wells were not infected (Fig. 3c ) and as most of the splenic cells that attached to the wells were CD68-positive (Fig. 3d) , it is likely that the observation of GFP expression represents a difference in the infection of monocytes/macrophages between WT and mutant viruses. In the case of guinea pigs, there are no commercially available antibodies to distinguish macrophages from monocytes. In the peritoneal and splenic monocytes/macrophages infected with the WT virus but not with the mutant viruses, expression of immediate-early (IE) and early antigens was observed by immunofluorescence assay (IFA) using a rabbit antibody against GST-IE protein (Hashimoto et al., 2013) and the mAb g-1, which recognizes a GPCMV early antigen (Katano et al., 2007) , respectively ( Fig. 3d ; data not shown). Since IFA using a combination of Alex Fluor 595-conjugated antirabbit and FITC-conjugated anti-mouse antibodies in place of the combination of Alex Fluor 595-conjugated antimouse and FITC-conjugated anti-rabbit antibodies resulted in the same conclusion (data not shown), detection of the IE protein was not due to the weak GFP fluorescence that remained after fixation with acetone.
Finally, PBMCs were prepared using Lympholyte-Rabbit Cell Separation Media (Cedarlane) and treated with PMA for 1-3 days. The PMA treatment increased the number of larger and GFP-positive cells after infection (Fig. 3e) . GFP expression was only observed in the PBMCs infected with the WT virus but not with the mutants (Fig. 3f) . Importantly, the GFP-positive cells, i.e. the infected cells, were CD68-positive (Fig. 3g) . Thus, each of GP129, GP131 and GP133 is required for the infection of monocytes/ macrophages. The cells were cultured for 3 days and analysed with the following primary antibodies: rabbit antibody against GFP and mAb against cytokeratin. FITC-conjugated goat antirabbit IgG F(ab9) 2 (Sigma) and Alexa Fluor 594-conjugated goat anti-mouse IgG F(ab9) 2 (Invitrogen) fragments were used as secondary antibodies. DAPI was used for counterstaining. Confocal images were captured with a LSM700 digital confocal microscope (Zeiss) and analysed using ZEN 2012 Lite.
In this study, we demonstrated that GP129/131/133 were essential for the infection of monocytes/macrophages but not for the infection of fibroblasts. Their role in the infection of epithelial cells was inconclusive. As it is known that the infection of primary cells, such as endothelial cells, with HCMV depends on their origin (Jarvis & Nelson, 2007) , analysis using guinea pig epithelial cells from different origins may be necessary. As monocytes/macrophages play an important role in the dissemination of CMV to peripheral organs (Stoddart et al., 1994; van der Strate et al., 2003; Smith et al., 2004) , the need for GP129-133 in monocytes/macrophage tropism could be one of the explanations for the growth defects of the 1.6 kb-deleted virus in animals. The MCMV genome locus corresponding to GP129-133 encodes M129-133. M129/131 encodes Mck-2, a CC chemokine (MacDonald et al., 1999) , and Mck-2 mutants show low-level viraemia and poor dissemination to the salivary glands (Saederup et al., 1999) . M132 is required for growth in the salivary glands (Manning et al., 1992) . RCMV also encodes Mck-2 (Voigt et al., 2005; Vomaske et al., 2012) . Recently, Wagner et al. (2013) demonstrated that MCMV Mck-2, by forming a complex with gH/gL, strongly promotes infection of macrophages. Interestingly, there is an apparent difference in the degree of dependence on the gH/gL complexes between Mck-2 and GP129/131/133 for viral entry into macrophages. As each of GP129/131/133 was almost absolutely required for the infection of macrophages, we hypothesize that the macrophage tropism, rather than the predicted function of GP129 as a CC chemokine (Auerbach et al., 2013) , is essential for viral dissemination in animals. 
